Hasse, Caroline
ORCID: 0000-0001-9757-1843, von Stein, Philipp
ORCID: 0000-0003-4548-3897, Althoff, Jan
ORCID: 0000-0001-9390-0160, Curio, Jonathan
ORCID: 0000-0002-3437-7450, Schäfer, Matthieu
ORCID: 0000-0003-1875-1163, Kirchner, Johannes
ORCID: 0009-0004-8357-1323, Rudolph, Felix
ORCID: 0000-0003-4948-6438, Gietzen, Thorsten
ORCID: 0000-0001-7948-202X, von Stein, Jennifer
ORCID: 0009-0000-3871-164X, Wrobel, Jan
ORCID: 0000-0002-1637-3413, Iliadis, Christos
ORCID: 0000-0001-7655-8500, Gerçek, Muhammed, Friedrichs, Kai P., Rudolph, Volker
ORCID: 0000-0001-5385-6839, Pfister, Roman
ORCID: 0000-0002-4358-5008, Baldus, Stephan
ORCID: 0000-0001-8259-1737 and Koerber, Maria I.
ORCID: 0000-0001-9073-9279
(2025).
Cardiac Remodeling Following Transcatheter Tricuspid Valve Annuloplasty for Tricuspid Regurgitation.
JACC: Cardiovascular Interventions, 18 (23).
pp. 2911-2921.
Elsevier.
ISSN 1936-8798
|
PDF
hasse-et-al-2025-cardiac-remodeling-following-transcatheter-tricuspid-valve-annuloplasty-for-tricuspid-regurgitation.pdf Bereitstellung unter der CC-Lizenz: Creative Commons Attribution. Download (822kB) |
Abstract
Background: Transcatheter tricuspid valve annuloplasty (TTVA) with the Cardioband has proved to be safe and effective in acutely reducing tricuspid regurgitation (TR). However, long-term outcomes, especially regarding right heart remodeling (RHR), are scarce. Objectives: The aim of this study was to assess long-term efficacy as well as RHR following TTVA. Methods: This retrospective, multicenter study included consecutive patients undergoing TTVA for severe TR at 2 German high-volume centers from 2019 to 2023. Right atrial and right ventricular (RV) parameters and NYHA functional class were assessed at baseline and follow-up. Results: A total of 156 patients were included, and the median time to follow-up was 435 days (Q1-Q3: 156-704 days). TR reduction to ≤2+ was observed in 71% and NYHA functional class improved to ≤II in 68% (P < 0.001 for both). Compared with baseline, right atrial area (36.0 ± 10.1 cm2 vs 30.4 ± 10.7 cm2), RV length (67.5 ± 9.4 mm vs 63.7 ± 9.1 mm), RV midventricular dimension (42.6 ± 8.6 mm vs 35.6 ± 7.8 mm), and RV basal dimension (47.8 ± 6.8 mm vs 42.6 ± 7.5 mm)were significantly reduced at follow-up (P < 0.001 for all). Notably, torrential to severe TR reduction still yielded remodeling (RV basal diameter 50 ± 8.1 mm vs 44 ± 8 mm; P = 0.007). RHR was associated with a decrease in vena contracta width (OR: 1.14; 95% CI: 1.03-1.30; P = 0.015). Conclusions: TTVA is associated with a significant and sustained reduction of TR for more than 1 year. Additionally, patients demonstrated distinct positive cardiac remodeling and functional improvement.
| Item Type: | Article |
| Creators: | Creators Email ORCID ORCID Put Code Gerçek, Muhammed UNSPECIFIED UNSPECIFIED UNSPECIFIED Friedrichs, Kai P. UNSPECIFIED UNSPECIFIED UNSPECIFIED |
| URN: | urn:nbn:de:hbz:38-812662 |
| Identification Number: | 10.1016/j.jcin.2025.10.010 |
| Journal or Publication Title: | JACC: Cardiovascular Interventions |
| Volume: | 18 |
| Number: | 23 |
| Page Range: | pp. 2911-2921 |
| Number of Pages: | 11 |
| Date: | December 2025 |
| Publisher: | Elsevier |
| ISSN: | 1936-8798 |
| Language: | English |
| Faculty: | Faculty of Medicine |
| Divisions: | Faculty of Medicine > Innere Medizin > Klinik III für Innere Medizin - Kardiologie, Pneumologie, Angiologie und internistische Intensivmedizin |
| Subjects: | Medical sciences Medicine |
| ['eprint_fieldname_oa_funders' not defined]: | Publikationsfonds UzK |
| Refereed: | Yes |
| URI: | http://kups.ub.uni-koeln.de/id/eprint/81266 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
![]() |
View Item |
https://orcid.org/0000-0001-9757-1843